Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 57 Show results per page	View Search Criteria \| Help With Results


1.		Phase I/III Induction with ADR/ARA-C/VCR/PRDL and Consolidation and Maintenance with ADR/ARA-C, ADR/AZC, MePRDL/VCR/6-MP/MTX, or ARA-C for ANLL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase I				Treatment				Closed				under 50								DFCI-76006 DFCI-VAPA-10

Last Modified: 6/1/1995


2.		Phase III Randomized Study of Chemotherapy with ChlVPP (CLB/VBL/PRDL/PCB) Alternating with PABlOE (PRDL/DOX/BLEO/VCR/VP-16) vs PABlOE Alone for Hodgkin's Disease (Summary Last Modified 06/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 69								CRC-TU-HO3001 EU-93029

Last Modified: 5/8/2007 First Published: 8/1/1994


3.		Phase III Randomized Study of CHOP (CTX/DOX/VCR/PRDL) vs MCOP (DHAD/CTX/VCR/PRDL) in Patients Aged 65 Years and Over with Intermediate- or High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				65 and over								CRC-TU-NH3003 EU-93028, NCT00002576

Last Modified: 12/6/2007 First Published: 1/1/1996


4.		Phase III Randomized Study of Prednisone Versus Dexamethasone Plus Cyclophosphamide, Daunorubicin, and Vincristine as Induction; Cytarabine, Mitoxantrone, Methotrexate, Leucovorin Calcium, and Asparaginase as Consolidation; Autologous Bone Marrow Transplantation; and Low- or High-Intensity Maintenance Chemotherapy With Cranial Irradiation in Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 60				Other				EORTC-06951 FRE-LALA-94, NCT00002700

Last Modified: 11/2/2005


5.		Phase III Randomized Study of Unrelated Donor BMT vs Continuing Chemotherapy for Childhood Acute Lymphoblastic Leukemia in First Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 15 at initial diagnosis								MRC-LEUK-UKALL-R2 EU-95039

Last Modified: 12/14/2005


6.		Phase III Randomized Study of 2 vs 3 Intensification Chemotherapy Blocks and of CNS Irradiation vs High-Dose IV MTX plus IT MTX vs Standard IT MTX for Childhood Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 1 and under 15								MRC-LEUK-UKALL-XI EU-95036

Last Modified: 9/29/2008 First Published: 6/1/1996


7.		Phase III Randomized International Study of Reduction in Intensification of the LMB 89 Regimen for non-Hodgkin's Lymphoma: Reduced Doses of CTX for Intermediate-Risk Patients and Less Maintenance Therapy for Intermediate-Risk and High-Risk Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 6 months to under 21				NCI				COG-C5961 CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, NCT00002757

Last Modified: 3/10/2005 First Published: 6/1/1997


8.		Phase III Study of Combination Vincristine/Doxorubicin/Prednisolone/Etoposide/Cyclophosphamide/Bleomycin (VAPEC-B) Chemotherapy and Involved Field Radiotherapy vs Mantle Radiotherapy in Early Stage Hodgkin's Disease (Summary Last Modified 09/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 to 75								MRC-UKLG-LY07 EU-97004, NCT00002987

Last Modified: 11/7/2007 First Published: 12/1/1999


9.		Phase III Randomized Study of Chemotherapy and Radiotherapy in Children With Standard or High Risk Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				1 to 17				NCI				DFCI-95001 DFCI-FDR001197, NCI-G99-1651, NCT00004034

Last Modified: 5/21/2007 First Published: 9/1/1998


10.		Phase III Randomized Study of a Four-Drug Anthracycline-Based Regimen or a Seven-Drug Hybrid or Eight-Drug Alternating Regimen in Patients With Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Not specified								MRC-UKLG-LY09 EU-98020, NCT00003421

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute